RFX1-dependent Activation of SHP-1 Induces Autophagy by a Novel Obatoclax Derivative in Hepatocellular Carcinoma Cells

Overview

Journal Oncotarget

Specialty Oncology

Date 2014 Jun 23

PMID 24952874

Citations 20

Authors

Jung-Chen Su

Ping-Hui Tseng

Cheng-Yi Hsu

Wei-Tien Tai

Jui-Wen Huang

Ching-Huai Ko

Mai-Wei Lin

Chun-Yu Liu

Kuen-Feng Chen

Chung-Wai Shiau

Affiliations

Soon will be listed here.

Abstract

Obatoclax is a small molecule which targets the Bcl-2 family, and is to treat leukemia, lymphoma and lung carcinoma. Previously, an obatoclax analogue, SC-2001, was found to disrupt the protein-protein interactions of the Bcl-2 family and also repress Bcl-XL and Mcl-1 expression via STAT3 inactivation. Here, we report a novel mechanism of autophagy induction by SC-2001 in liver cancer cells. The findings indicate that SC-2001 induced the autophagy marker LC3-II in four hepatocellular carcinoma (HCC) cells. Autophagosomes induced by SC-2001-treated cells were confirmed by electron microscopy. SC-2001 activated SHP-1, dephosphorylated STAT3 and Mcl-1, and subsequently released free beclin 1. Overexpression of STAT3 and Mcl-1 in PLC5 cells attenuated the induction of SC-2001 on autophagy. Abolishment of SHP-1 by a specific inhibitor aboragated the autophagic effects induced by SC-2001. In addition, it was further revealed that RFX-1, a transcription factor of SHP-1, is a critical regulator in SC-2001-mediated autophagy. Downregulation of RFX-1 by si-RNA protected cells from SC-2001-induced autophagy. Importantly, Huh7 tumor-bearing nude mice treated with SC-2001 showed downregulation of Mcl-1 and p-STAT3 protein expression and upregulation of SHP-1, LC3II, and RFX-1 protein expression. In summary, our data suggest that SC-2001 induces autophagic cell death in a RFX1/SHP-1/STAT3/Mcl-1 signaling cascade.

Citing Articles

Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review).

Chen Y, Hsieh C, Chu P, Chen J, Huang Y, Chen C Oncol Rep. 2023; 49(3).

PMID: 36660927 PMC: 9887465. DOI: 10.3892/or.2023.8485.

The Interaction Between Autophagy and JAK/STAT3 Signaling Pathway in Tumors.

Xu J, Zhang J, Mao Q, Wu J, Wang Y Front Genet. 2022; 13:880359.

PMID: 35559037 PMC: 9086235. DOI: 10.3389/fgene.2022.880359.

RFX1: a promising therapeutic arsenal against cancer.

Issac J, Raveendran P, Das A Cancer Cell Int. 2021; 21(1):253.

PMID: 33964962 PMC: 8106159. DOI: 10.1186/s12935-021-01952-6.

Protective Effect of Curcumin on Bone Trauma in a Rat Model via Expansion of Myeloid Derived Suppressor Cells.

Zhang F, Liu F, Yu S, Zhang G, Li J, Sun X Med Sci Monit. 2020; 26:e924724.

PMID: 33184252 PMC: 7670833. DOI: 10.12659/MSM.924724.

Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation.

Kumar S, Nanduri R, Bhagyaraj E, Kalra R, Ahuja N, Chacko A Autophagy. 2020; 17(9):2273-2289.

PMID: 32917126 PMC: 8496711. DOI: 10.1080/15548627.2020.1822088.

References

He C, Klionsky D . Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009; 43:67-93. PMC: 2831538. DOI: 10.1146/annurev-genet-102808-114910. View

Siegelin M, Raskett C, Gilbert C, Ross A, Altieri D . Sorafenib exerts anti-glioma activity in vitro and in vivo. Neurosci Lett. 2010; 478(3):165-70. PMC: 3198851. DOI: 10.1016/j.neulet.2010.05.009. View

Amaravadi R, Lippincott-Schwartz J, Yin X, Weiss W, Takebe N, Timmer W . Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011; 17(4):654-66. PMC: 3075808. DOI: 10.1158/1078-0432.CCR-10-2634. View

Nguyen M, Marcellus R, Roulston A, Watson M, Serfass L, Murthy Madiraju S . Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci U S A. 2007; 104(49):19512-7. PMC: 2148320. DOI: 10.1073/pnas.0709443104. View

Dalby K, Tekedereli I, Lopez-Berestein G, Ozpolat B . Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy. 2010; 6(3):322-9. PMC: 2914492. DOI: 10.4161/auto.6.3.11625. View

Amin S, Kumar A, Nilchi L, Wright K, Kozlowski M . Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors. Mol Cancer Res. 2011; 9(8):1112-25. DOI: 10.1158/1541-7786.MCR-11-0097. View

Tai W, Cheng A, Shiau C, Huang H, Huang J, Chen P . Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. J Hepatol. 2011; 55(5):1041-8. DOI: 10.1016/j.jhep.2011.01.047. View

Bergmann A . Autophagy and cell death: no longer at odds. Cell. 2007; 131(6):1032-4. PMC: 2502067. DOI: 10.1016/j.cell.2007.11.027. View

Mulcahy Levy J, Thorburn A . Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther. 2011; 131(1):130-41. PMC: 3539744. DOI: 10.1016/j.pharmthera.2011.03.009. View

10.

Chen K, Su J, Liu C, Huang J, Chen K, Chen W . A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Lett. 2012; 321(1):27-35. DOI: 10.1016/j.canlet.2012.03.023. View

11.

Hurwitz J, McCoy F, Scullin P, Fennell D . New advances in the second-line treatment of small cell lung cancer. Oncologist. 2009; 14(10):986-94. DOI: 10.1634/theoncologist.2009-0026. View

12.

Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson C . Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004; 6(12):1221-8. DOI: 10.1038/ncb1192. View

13.

Bonapace L, Bornhauser B, Schmitz M, Cario G, Ziegler U, Niggli F . Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest. 2010; 120(4):1310-23. PMC: 2846044. DOI: 10.1172/JCI39987. View

14.

Martin A, Mitchell C, Rahmani M, Nephew K, Grant S, Dent P . Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther. 2009; 8(21):2084-96. PMC: 3887451. DOI: 10.4161/cbt.8.21.9895. View

15.

Su J, Chen K, Chen W, Liu C, Huang J, Tai W . Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists. Eur J Med Chem. 2012; 56:127-33. DOI: 10.1016/j.ejmech.2012.08.024. View

16.

Tang Y, Hamed H, Cruickshanks N, Fisher P, Grant S, Dent P . Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol. 2012; 81(4):527-40. PMC: 3310419. DOI: 10.1124/mol.111.076851. View

17.

Erlich S, Mizrachy L, Segev O, Lindenboim L, Zmira O, Adi-Harel S . Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy. 2007; 3(6):561-8. DOI: 10.4161/auto.4713. View

18.

Apel A, Herr I, Schwarz H, Rodemann H, Mayer A . Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008; 68(5):1485-94. DOI: 10.1158/0008-5472.CAN-07-0562. View

19.

Voss V, Senft C, Lang V, Ronellenfitsch M, Steinbach J, Seifert V . The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res. 2010; 8(7):1002-16. DOI: 10.1158/1541-7786.MCR-09-0562. View

20.

Klionsky D, Emr S . Autophagy as a regulated pathway of cellular degradation. Science. 2000; 290(5497):1717-21. PMC: 2732363. DOI: 10.1126/science.290.5497.1717. View